Cargando…
Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals
AIM: Lung cancer screening reduces mortality. We aim to validate the performance of Lung EpiCheck, a six-marker panel methylation-based plasma test, in the detection of lung cancer in European and Chinese samples. METHODS: A case–control European training set (n=102 lung cancer cases, n=265 controls...
Autores principales: | Gaga, Mina, Chorostowska-Wynimko, Joanna, Horváth, Ildikó, Tammemagi, Martin C., Shitrit, David, Eisenberg, Vered H., Liang, Hao, Stav, David, Levy Faber, Dan, Jansen, Maarten, Raviv, Yael, Panagoulias, Vasileios, Rudzinski, Piotr, Izbicki, Gabriel, Ronen, Ohad, Goldhaber, Adiv, Moalem, Rawia, Arber, Nadir, Haas, Ilana, Zhou, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806969/ https://www.ncbi.nlm.nih.gov/pubmed/33122336 http://dx.doi.org/10.1183/13993003.02682-2020 |
Ejemplares similares
-
Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease
por: Szpechcinski, A, et al.
Publicado: (2015) -
Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer
por: Chorostowska-Wynimko, J, et al.
Publicado: (2009) -
The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence
por: Mancini, Mariangela, et al.
Publicado: (2020) -
Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022) -
Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein
por: Lechowicz, Urszula, et al.
Publicado: (2020)